Endo International PLC (LTS:0Y5F)

$ 0.0006 0 (0%) Market Cap: 141,000.00 Enterprise Value: -772.69 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 50/100

Q1 2022 Endo International PLC Earnings Call Transcript
May 06, 2022

$1.43 (-31.59%)

Earnings
Q4 2021 Endo International PLC Earnings Call Transcript
Mar 01, 2022

$2.45 (-24.61%)

Earnings
Endo International PLC at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2022
Q3 2021 Endo International PLC Earnings Call Transcript
Nov 05, 2021

$6.08 (+23.34%)

Earnings
Q2 2021 Endo International PLC Earnings Call Transcript
Aug 06, 2021

$4.4 (-7.76%)

Earnings
Endo International PLC at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
May 19, 2021
Q1 2021 Endo International PLC Earnings Call Transcript
May 07, 2021

$5.31

Earnings
Endo International PLC at JPMorgan Global High Yield & Leveraged Finance Conference (Virtual) Transcript
Mar 01, 2021
Q4 2020 Endo International PLC Earnings Call Transcript
Feb 26, 2021

$8.05 (-12.95%)

Earnings
Endo International PLC at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2021
Endo International PLC at Bank of America Leveraged Finance Virtual Conference Transcript
Nov 30, 2020
Q3 2020 Endo International PLC Earnings Call Transcript
Nov 06, 2020

$5.64

Earnings
Q2 2020 Endo International PLC Earnings Call Transcript
Aug 06, 2020

$3.87

Earnings
Q1 2020 Endo International PLC Earnings Call Transcript
May 07, 2020

$4.53

Earnings
Q4 2019 Endo International PLC Earnings Call Transcript
Feb 26, 2020

$4.82

Earnings
Endo International PLC at JPMorgan Healthcare Conference Transcript
Jan 13, 2020
Endo International PLC at Bank of America Merrill Lynch Leveraged Finance Conference Transcript
Dec 03, 2019
Q3 2019 Endo International PLC Earnings Call Transcript
Nov 05, 2019

$4.76

Earnings
Q2 2019 Endo International PLC Earnings Call Transcript
Aug 06, 2019

$3.27

Earnings
Q1 2019 Endo International PLC Earnings Call Transcript
May 09, 2019

$8.03

Earnings
Q4 2018 Endo International PLC Earnings Call Transcript
Feb 28, 2019

$10.43

Earnings

Endo International PLC at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 07:50PM GMT

Release Date Price: $6.67

Transcript

Christopher Thomas Schott

JPMorgan Chase & Co, Research Division - Senior Analyst

Good afternoon, everybody. I'm Chris Schott at JPMorgan. I'm very pleased to be introducing Endo today. From the company we have, Blaise Coleman, the company's President and CEO.

As a reminder, we are going to have Blaise make a presentation here and then we'll open up to a Q&A session. (Operator Instructions)

With that, let me turn it over to Blaise for the presentation.

Blaise Coleman

Endo International plc - President, CEO & Director

Good afternoon, Chris, and it's good to be with you. And I really appreciate the opportunity to present at today's conference and appreciate the interest by all those watching and listening.

I am joined here at the conference by our CFO, Mark Bradley, and our Global Head of Commercial Operations, Patrick Barry, as well as our Investor Relations team.

I've had the privilege of being Endo's CEO for the last 10 months. And this has been my first opportunity to speak here at the JPMorgan healthcare

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.